Skip to content

Acceptance and commitment therapy as an intervention to improve quality of life and activity-engagement in patients with multiple sclerosis.

Acceptance and commitment therapy as an intervention to improve quality of life and activity-engagement in patients with multiple sclerosis. - ACTinMS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57763
Enrollment
8
Registered
2014-05-27
Start date
2014-06-19
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MS Multiple sclerosis

Interventions

The therapists will use an 8-session group protocol of two hours, based on the work of Jansen & Batink (2014) and Luoma & Hayes (2009). Patients will receive a book with background information and e

Sponsors

Overige Ziekenhuizen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - age 18 to 60 years; - a clinically definite MS diagnosis (McDonald-criteria 2010) (Polman et al., 2010); - reduced activity engagement: two or more restrictions on the Utrecht Scale for Evaluation of Revalidation-Participation (User-P, Van der Zee, et al., 2010) ; - problems accepting the illness and - motivation for an 8-session psychological group intervention focusing on acceptance in chronic illness, based on clinical judgment of a psychologist

Exclusion criteria

Exclusion criteria: - MS relapse or corticosteroid use within the past 4 weeks - Severe psychiatric disorders (e.g. a current severe depressive episode, psychosis, social phobia, delirium, dementia or severe cognitive impairment) - Non-fluent in Dutch language - Intellectual disability or lack of verbal abstraction, based on educational history and clinical judgment - Earlier treatment based on ACT and/or MBCT.

Design outcomes

Primary

MeasureTime frame
The Utrecht Scale for Evaluation of Revalidation-Participation (USER-P) will be used to measure the level of activity and participation in the areas vocational activity, leisure and social activity weekly. General QoL will also be measured with the USER-P. The last subscale of this questionnaire asks for satisfaction in the areas housekeeping, vocational activity, leisure and social activity. Health related QoL will be measured with the Multiple Sclerosis Quality of Life instrument (MS-QoL-54). The MS-QoL will be completed together with the secondary study parameters at start of the waiting list period, at start of the intervention, at the end of the intervention and one and three months after completing the intervention. Patients will be asked daily to score how content they are with their daily life on a visual analogue scale.

Secondary

MeasureTime frame
Psychological flexibility will be measured weakly with the Acceptance and Action Questionnaire (AAQ-II) and the Cognitive Fusion Questionnaire (CFQ-13), and with the Flexibility Index Test (FIT-60) together with the other secondary study parameters. Symptoms of depression and anxiety will be measured with the Hospital Anxiety and Depression Scale (HADS). Fatigue will be measured with the fatigue severity subscale of the Checklist Individual Strenght-20 (CIS-20). Coping styles will be measured with the Coping Inventory of Stressful Situations (CISS). Proactive coping will be measured with the Utrecht Proactive Coping Competence Scale (UPCC).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)